Latest filing published 02 Mar 2022 for Crinetics Pharmaceuticals, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Ajay Madan: trading record in brief
Ajay Madan, listed as senior executive, appears in our data through filings on Crinetics Pharmaceuticals, Inc. shares, published by SEC (Form 4). We count 4 filings; the first trade dates from 28 October 2021 and the latest from 1 March 2022.
On the market, this insider has only sold: 2 sales, €368k in total. Other entries cover 1 share grant and 1 option exercise. 2022 to date brings no purchases and 2 sales.
The newest entry dates from 2 March 2022: an open-market sale of €160k, in Crinetics Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Ajay Madan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,950 shares0Common StockSEC:0001209191-22-015131:0
- 13,411 shares@ US$17.827575.8% of flowCommon StockSEC:0001209191-22-008061:0
- 106,383 shares@ US$0.7324.2% of flowCommon StockSEC:0001209191-21-062263:0
3 of 3 declarations
